Stay updated on Pembrolizumab in Advanced Head and Neck Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Advanced Head and Neck Clinical Trial page.

Latest updates to the Pembrolizumab in Advanced Head and Neck Clinical Trial page
- ChecktodayChange DetectedThe page now displays Revision: v3.6.2, replacing the previous Revision: v3.6.0. This indicates a recent deployment update to the site's software or content management system.SummaryDifference0.0%

- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe page now features new user guidance sections and recruitment status language, and the Interventions header formatting has been adjusted from 'Intervention / Treatment' to 'Intervention/Treatment', accompanied by a new revision tag (v3.6.0) indicating an updated page version.SummaryDifference0.1%

- Check21 days agoChange DetectedAdded 'Revision: v3.5.5' and removed 'Revision: v3.5.4' text on the page. This indicates a new revision label for the document/versioning metadata.SummaryDifference0.0%

- Check43 days agoChange DetectedNew trial sites were added across multiple countries (including the US, Argentina, Hungary, Japan, the UK, Poland, Russia, South Korea, and others) and several existing sites were removed, reflecting a revised geographic footprint for NCT03765918. This update changes where participants can enroll and where data collection will occur.SummaryDifference0.6%

- Check64 days agoChange DetectedThe page’s footer revision label was updated from **v3.5.2** to **v3.5.3**, reflecting a software/version rollout rather than a change to the clinical trial record.SummaryDifference0.0%

- Check71 days agoChange DetectedAdded Revision: v3.5.2 and removed Revision: v3.5.0.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab in Advanced Head and Neck Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Advanced Head and Neck Clinical Trial page.